There are to be no vaccinations: vaccinations, medicines and herbs are forbidden.
Original statement
عقلك من الصندوق انت راجل صاحب فكر ماشي ما فيش تطعيمات يا باشا استاذ سوزي سوسي ممنوع التطعيمات ممنوع الادويه ممنوع الاعشاب كل حاجه قديمه للبيع ساره السيد ازيك ما انا لايف النهارده
verbatim according to source. Translation by the project; the Arabic wording is authoritative.
Translation
There are to be no vaccinations: vaccinations, medicines and herbs are forbidden.
Origin
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- Dr Diaa Al Awady د ضياء العوضي is live!صباح الخير اتباع العوضي (Open source)
- Published
- 19 September 2025
- Timestamp
- 1:06:40 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)
- Attribution uncertainty
- Transcript is YouTube CC or machine-generated (no timestamps); wording may contain speech-recognition errors. Speaker attribution within live streams/podcasts is not marked in the transcript; the excerpt was judged to be Elawady's own speech from context. Recurrence = number of archive transcripts matching the keyword pattern ['تطعيمات|التطعيمات|لقاح|اللقاحات'] (approximate; includes re-uploads/clips; 30 distinct text passages).
- Claimed mechanism
Not stated in this excerpt.
- Claimed health effect
Not specified.
- Population concerned
Everyone (followers).
- Geographic restriction by Elawady
none found; he does not limit this statement to a country or to a production system
Diverging source versions
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- Dr Diaa Al Awady د ضياء العوضي is live! اصل الأمراض في فهم الاعراض✌️✌️✌️ (Open source)
- Published
- 5 September 2025
- Timestamp
- not available (transcript has no timings)
- Attribution uncertainty
- Further video in which the same statement recurs; no excerpt recorded. Archive transcript without timestamps.
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- Dr Diaa Al Awady د ضياء العوضي is live! يعني ايه تجويع الخلايا من السكر و ايه علاقتها بمقاومة الانسو (Open source)
- Published
- 2 November 2025
- Timestamp
- not available (transcript has no timings)
- Attribution uncertainty
- Further video in which the same statement recurs; no excerpt recorded. Archive transcript without timestamps.
لا ما حدش ياخد تطعيم مدارس خالص ولا يمد في ايده في جسمه بشكه ابره ولا بنقطه ولا بتطعيم ولا اي حاجه
Nobody should take school vaccinations at all, nor let anyone put a needle, a drop or a vaccination into their body.
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- Dr Diaa Al Awady د ضياء العوضي is live! الالتهاب ايه هوه ؟ (Open source)
- Published
- 26 September 2025
- Timestamp
- 0:41:13 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)
- Attribution uncertainty
- Archive transcript (YouTube CC or AI-generated); no timestamps; 'published' is the date listed by the archive and may be the upload date. Live-stream transcripts can contain viewer comments read aloud; the quoted passage was checked in context to be spoken by Elawady.
Scientific assessment
False – The statement contradicts the robust evidence.
Certainty of evidence: high – Further research is very unlikely to change the assessment.
1. What was claimed?
There should be no vaccinations; vaccinations, medicines and herbs are forbidden (including school vaccinations).
2. What is demonstrably correct?
Vaccines have side effects, and the Cochrane review quantifies them: MMR-type vaccines cause febrile seizures in about 1 per 1150-1700 doses and ITP in about 1 per 40,000 doses (lower than after natural infection) (I-INTB-16); inactivated influenza vaccine slightly increases fever (1.5% to 2.3%) and its absolute benefit in healthy adults is modest (I-INTB-13). A systematic review of controlled studies found high-strength evidence for MMR and febrile seizures and moderate evidence for rotavirus vaccine and intussusception, all extremely rare (I-SRC-125).
3. What is wrong or exaggerated?
A ban on vaccination contradicts strong evidence of benefit: measles vaccine effectiveness 95% after one dose and 96% after two (I-INTB-16); about 154 million deaths averted since 1974, including 101 million infants (I-INTB-15). No association with autism (OR 0.99) (I-INTB-17) or with encephalitis, type 1 diabetes, asthma or leukaemia (I-INTB-16). In 657,461 Danish children, MMR vaccination was not associated with autism (HR 0.93, 0.85-1.02; I-SRC-104).
4. What remains unclear?
Modelled death estimates depend on assumptions (I-INTB-15).
5. Which studies support it?
I-INTB-16, I-SRC-125 (rare side effects exist), I-INTB-13 (modest benefit in healthy adults).
6. Which studies contradict it?
I-INTB-15, I-INTB-16, I-INTB-17, I-INTB-13, I-SRC-104, I-SRC-105.
7. What applies to Germany and Europe?
Germany's Standing Committee on Vaccination (STIKO) publishes a standard vaccination calendar for infants, children, adolescents and adults (Impfkalender 2026, rki.de/impfkalender, fetched 2026-10-26).
8. What is known about Egypt?
Egypt has compulsory childhood vaccinations. WHO regional data show 96-97% first-dose and 95-96% second-dose measles vaccine coverage in Egypt in 2023-2024, measles incidence falling from 2.2 per million to zero, and verified sustained measles and rubella elimination for 2024, while low-coverage countries in the region had large outbreaks, mostly among unvaccinated children (I-SRC-105).
9. What practical conclusion is appropriate?
Follow the national vaccination schedule; discuss any concerns or contraindications with a physician.
Assessment details
- Rationale for certainty of evidence
High-certainty evidence: MMR vaccination prevents about 95% of measles after one dose (I-INTB-16); vaccination averted an estimated 154 million deaths since 1974 (I-INTB-15); influenza vaccine roughly halves confirmed influenza (I-INTB-13); vaccines are not associated with autism (I-INTB-17).
- Source quality
Machine transcript of a live stream; wording may contain recognition errors; meaning checked in context. Repeated in other live streams (e.g. against school vaccinations).
- Regional transferability
Universal; Egypt has a national childhood immunisation programme.
- Individual exceptions
Some people have specific contraindications (e.g. severe allergy to a vaccine component, some immunodeficiencies for live vaccines); these are decided individually.
- Regional scope of the claim
- general (biological/medical)
- Last reviewed
- 26 October 2026 provisional
Scientific evidence in detail
Scientifically refuted – High-quality evidence shows the opposite, or the claim contradicts well-established physiology.
Research question: Does avoiding all vaccinations (and medicines and herbs) improve health compared with following national vaccination schedules?
Research question in detail (PICO)
- Population
- Children and adults (Egypt and general)
- Intervention or exposure
- No vaccination
- Comparison
- Vaccination according to national schedules
- Geographic scope
- universal biology; Egypt-specific coverage and measles data
- Outcomes
- Vaccine-preventable disease incidence and deaths
- Serious adverse events
- Autism
Study results as reported by the authors. Our assessment follows below.
What speaks for the claim?
Safety of routine childhood vaccines
Maglione MA et al.. Pediatrics 2014 · PMID 25086160 · DOI 10.1542/peds.2014-1079 Systematic reviewabstract checkednewly addedSystematic review of routine childhood vaccine safety.
- Actual result
- High strength of evidence for MMR and febrile seizures; moderate for rotavirus vaccine and intussusception; complications of varicella vaccine in immunodeficiency; events extremely rare.
- Methodological quality
- moderate
- Relevance
- direct for harms
- Limitations
- No pooling; US formulations.
Measles-mumps-rubella vaccines work and are safe
Di Pietrantonj C et al.. Cochrane Database Syst Rev 2021 · PMID 34806766 · DOI 10.1002/14651858.CD004407.pub5 Systematic reviewabstract checkedCochrane MMR(V) review: harms.
- Actual result
- Febrile seizures about 1 per 1150-1700 doses; ITP about 1 per 40,000 doses.
- Methodological quality
- high
- Relevance
- direct for harms
- Limitations
- Harms are rare.
What speaks against the claim?
50 years of vaccination: lives saved
Shattock AJ et al.. Lancet 2024 · PMID 38705159 · DOI 10.1016/S0140-6736(24)00850-X Risk assessmentfull text, structured risk-of-bias assessmentModelling of 50 years of the Expanded Programme on Immunization.
- Actual result
- About 154 million deaths averted since 1974, including 101 million infants.
- Methodological quality
- moderate (model)
- Relevance
- direct (population benefit)
- Limitations
- Model assumptions.
Measles-mumps-rubella vaccines work and are safe
Di Pietrantonj C et al.. Cochrane Database Syst Rev 2021 · PMID 34806766 · DOI 10.1002/14651858.CD004407.pub5 Systematic reviewabstract checkedCochrane MMR(V) review: effectiveness.
- Actual result
- Measles vaccine effectiveness 95% after one dose and 96% after two.
- Methodological quality
- high
- Relevance
- direct
- Limitations
- Observational components.
Measles in the Eastern Mediterranean 2023-2024
Farid M et al.. Vaccines (Basel) 2026 · PMID 42646678 · DOI 10.3390/vaccines14080659 Ecological studyfull text checkednewly addedWHO EMR measles data 2023-2024 (full text).
- Actual result
- Egypt MCV1/MCV2 96/95% (2023), 97/96% (2024); measles incidence 2.2 -> 0 per million; verified sustained elimination 2024; regional outbreaks concentrated in low-coverage settings and in zero-/one-dose children.
- Methodological quality
- moderate (surveillance)
- Relevance
- direct, Egypt-specific
- Limitations
- Descriptive.
What does the overall evidence say?
Editorial assessment based on the studies above – not itself a study result.
Which position is better supported?
Vaccination according to national schedules; individual contraindications assessed by physicians.
Why some studies weigh more
Cochrane reviews, very large cohorts and WHO surveillance outweigh rare, quantified harms. Overlapping Cochrane/meta-analytic sources were counted once.
Is a causal relationship established? Yes, established RCTs and large cohorts show vaccines prevent infection and death; autism link excluded in very large cohorts.
Remaining uncertainty
Modelled death estimates depend on assumptions; benefit size differs by vaccine.
Justified conclusion
A general ban on vaccination would remove large, proven protection; Egypt's measles elimination depends on its high coverage.
Why do studies seem to disagree?
Harms evidence (I-SRC-125, I-INTB-16) and benefit evidence do not conflict: both show rare harms and large benefits. Claim also bundles medicines and herbs, which are different questions.
Does this depend on the country?
- General biological effects
- Immunology universal.
- Eating habits
- Not applicable.
- Origin of the food
- Not applicable.
- Contaminants
- Not applicable.
- National production conditions
- Not applicable.
- Legal rules
- Egypt has compulsory childhood vaccination; Germany's STIKO publishes a standard schedule (Impfkalender 2026).
- Actual monitoring data
- WHO/UNICEF coverage and EMR surveillance (I-SRC-105) show high coverage and measles elimination in Egypt.
A regional difference is supported by robust data.
Statistical re-check
- Incidence recalculation and HR CI symmetry – 6517/5,025,754 = 129.7/100,000 (matches); HR 0.93 (0.85-1.02) symmetric on log scale recalculated
- Regional incidence change – EMR +5.0% (110.8 -> 116.3/million); Egypt 2.2 -> 0 recalculated
Certainty of the overall evidence (GRADE, simplified)
- Main outcome
- Prevention of measles (and other vaccine-preventable disease) by vaccination
- Starting level
- high (randomised trials)
- Reasons for upgrading
- large effect (95% effectiveness)
- Result
- high
Simplified assessment by a single reviewer, following the GRADE approach; not a formal GRADE panel. GRADE rates the body of evidence for one outcome, not individual studies.
Clinical guidelines and official statements checked
- WHO: Measles fact sheet (2026) · Original publication
About 95,000 measles deaths in 2024; vaccination averted nearly 59 million deaths 2000-2024; vaccine safe, effective and inexpensive; two doses recommended; unvaccinated young children and pregnant persons at highest risk. - RKI/STIKO: Impfkalender 2026 (STIKO recommendations, Epid Bull 4/2026) (2026) · Original publication
RKI publishes the 2026 standard vaccination calendar for infants, children, adolescents and adults; detailed timings are in the linked PDF (not read). - CDC: Child and Adolescent Immunization Schedule by Age (addendum updated 2 July 2025) (2025) · Original publication
Lists routine childhood vaccines including MMR (2 doses), DTaP, polio, Hib, pneumococcal, hepatitis B; page last updated July 2025.
Search strategy
Documented literature searches for this review (search strings in the original database syntax).
| Database | Date | Search | Looking for | Hits | Included |
|---|---|---|---|---|---|
| PubMed | 26 October 2026 | safety of vaccines used for routine immunization systematic review adverse events children | supporting evidence | 26 | |
| Europe PMC | 26 October 2026 | (vaccin* AND ("serious adverse events" OR harms) AND children AND (systematic review OR meta-analysis)) AND PUB_YEAR:[2014 TO 2026] | supporting evidence | 5563 | |
| PubMed | 26 October 2026 | measles mumps rubella vaccination autism nationwide cohort study | contradicting evidence | 2 | |
| Europe PMC | 26 October 2026 | (Egypt OR Egyptian) AND (measles OR diphtheria OR polio OR pertussis) AND (vaccination coverage OR outbreak OR immunization) | contradicting evidence | 5573 | |
| Europe PMC | 26 October 2026 | (vaccin*) AND ("Cochrane Database Syst Rev") AND (children) AND (mortality OR efficacy OR effectiveness) AND PUB_YEAR:[2019 TO 2026] | contradicting evidence | 500 | |
| WHO / CDC / RKI websites | 26 October 2026 | WHO measles fact sheet; CDC child and adolescent immunization schedule; RKI Impfkalender 2026 (web search 'STIKO Impfkalender 2026 Empfehlungen Säuglinge Masern rki.de') | guidelines | 3 |
How deeply was this checked?
7 linked studies: 2 checked in full text (1 of them with a structured risk-of-bias assessment), 5 on the basis of the abstract, 0 bibliographically only. No formal assessment with two independent reviewers and no independent human expert review has taken place yet.
Last scientific review: 26 October 2026
History of the verdict
- 25 October 2026 · Phase 1 · Initial assessment: False (high)
- 26 October 2026 · Phase 4 (systematic evidence review) · Re-examined with extended evidence; verdict unchanged: False (high)
New Danish cohort, safety review and Egypt-specific WHO data confirm the verdict; wording sharpened.
New sources: I-SRC-104 I-SRC-105 I-SRC-125
In plain language
Dr. Elawady told followers that vaccinations are forbidden, including school vaccinations. Vaccines can have side effects, such as fever and, rarely, febrile seizures. But large reviews show that the measles vaccine prevents about 95% of cases and that vaccines have saved well over 100 million lives since 1974. Vaccines are not linked to autism. Refusing vaccines puts children and others at risk.
Studies on this claim
Studies supporting the claim (0)
No studies in this group.
Studies contradicting or limiting the claim (6)
-
50 years of vaccination: lives saved
Shattock AJ et al.. Lancet 2024 · PMID 38705159 · DOI 10.1016/S0140-6736(24)00850-XRisk assessmentindependent cross-checkfull text, structured risk-of-bias assessment★ key studyVaccines against 14 diseases averted an estimated 154 million deaths since 1974 (about 94 million by measles vaccine alone), mostly in young children.
Vaccination averted about 154 million deaths.
Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Estimate deaths averted by vaccination
- How was the study done?
Modelling
- How many people, animals or samples were studied?
Global
- What was actually found?
154 million deaths averted
- How large was the observed effect?
40% of infant-mortality decline
- What do the results mean in everyday life?
Vaccination is one of the main reasons far fewer children die today.
- What are the study's limitations?
Model-based counterfactual; no formal uncertainty bounds; WHO-funded with WHO-linked authors
- What does it say about Elawady's specific claim?
Contradicts 'no vaccinations'.
- Do the results apply to Germany and Europe?
High
- What can explicitly not be concluded from this study?
Model estimates are not direct observations.
-
Measles-mumps-rubella vaccines work and are safe
Di Pietrantonj C et al.. Cochrane Database Syst Rev 2021 · PMID 34806766 · DOI 10.1002/14651858.CD004407.pub5Systematic reviewindependent cross-checkabstract checked★ key studyOne dose prevents about 95% of measles; serious side effects are rare and no link to autism was found.
MMR is highly effective; rare harms quantified.
Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Assess MMR/MMRV
- How was the study done?
Cochrane review
- How many people, animals or samples were studied?
138 studies, 23 million children
- What was actually found?
High effectiveness, rare harms
- How large was the observed effect?
measles RR 0.05
- What do the results mean in everyday life?
The measles vaccine prevents almost all cases; rare side effects such as febrile seizures exist.
- What are the study's limitations?
Observational data; abstract only
- What does it say about Elawady's specific claim?
Contradicts 'no vaccinations'.
- Do the results apply to Germany and Europe?
High
-
Vaccines do not cause autism
Taylor LE, Swerdfeger AL, Eslick GD. Vaccine 2014 · PMID 24814559 · DOI 10.1016/j.vaccine.2014.04.085Meta-analysisindependent cross-checkabstract checkedIn over 1.2 million children, vaccination was not linked to autism.
No vaccine-autism link.
Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Test vaccine-autism link
- How was the study done?
Meta-analysis
- How many people, animals or samples were studied?
10 studies
- What was actually found?
No association
- How large was the observed effect?
OR 0.99
- What do the results mean in everyday life?
Fear of autism is not a reason to avoid vaccines.
- What are the study's limitations?
Observational; abstract only
- What does it say about Elawady's specific claim?
Contradicts vaccine rejection based on autism fears.
- Do the results apply to Germany and Europe?
High
-
Flu vaccines in healthy adults
Demicheli V et al.. Cochrane Database Syst Rev 2018 · PMID 29388196 · DOI 10.1002/14651858.CD001269.pub6Meta-analysisindependent cross-checkabstract checkedVaccination roughly halves confirmed influenza (2.3% to 0.9%); absolute benefit is modest.
Vaccines reduce influenza; no serious harms found.
Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Assess influenza vaccines
- How was the study done?
Cochrane review
- How many people, animals or samples were studied?
52 trials, >80,000 adults
- What was actually found?
Fewer influenza cases; small effect on hospitalisation
- How large was the observed effect?
RR 0.41
- What do the results mean in everyday life?
Flu shots reduce flu but do not abolish it; nothing removes seasonal flu from a country in three weeks.
- What are the study's limitations?
Old trials; abstract only
- What does it say about Elawady's specific claim?
Contradicts both the 3-week claim and blanket vaccine rejection, while showing modest absolute benefit.
- Do the results apply to Germany and Europe?
High
- What can explicitly not be concluded from this study?
Does not address older or high-risk adults.
-
MMR vaccine does not cause autism
Hviid A et al.. Ann Intern Med 2019 · PMID 30831578 · DOI 10.7326/M18-2101Cohort studyindependent cross-checkabstract checked★ key studyAmong 657,461 Danish children, vaccinated children did not have more autism than unvaccinated ones.
No autism risk from MMR in 657,461 children.
Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Test MMR-autism link
- How was the study done?
Nationwide cohort
- How many people, animals or samples were studied?
657,461 children
- What was actually found?
No increased autism risk
- How large was the observed effect?
HR 0.93 (0.85-1.02)
- What do the results mean in everyday life?
Fear of autism is not a reason to avoid MMR
- What are the study's limitations?
Observational
- What does it say about Elawady's specific claim?
Contradicts banning vaccines
- Do the results apply to Germany and Europe?
High
-
Measles in the Eastern Mediterranean 2023-2024
Farid M et al.. Vaccines (Basel) 2026 · PMID 42646678 · DOI 10.3390/vaccines14080659Ecological studyindependent cross-checkfull text checked★ key studyEgypt, with about 96% of children vaccinated twice, had no measles in 2024, while low-coverage neighbours had large outbreaks.
Egypt achieved measles elimination with ~96% coverage; outbreaks concentrate among unvaccinated children in the region.
Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Track measles elimination in the region
- How was the study done?
Analysis of WHO surveillance data
- How many people, animals or samples were studied?
22 countries
- What was actually found?
Outbreaks where coverage is low; elimination in Egypt
- How large was the observed effect?
Egypt 0 cases per million in 2024
- What do the results mean in everyday life?
High vaccination keeps measles away
- What are the study's limitations?
Descriptive data; under-reporting
- What does it say about Elawady's specific claim?
Contradicts banning vaccines
- Do the results apply to Germany and Europe?
Egypt-specific
- What can explicitly not be concluded from this study?
Causal effect size (not a trial)
No study in this group is marked as key.
Studies with mixed or unclear results (1)
-
Safety of routine childhood vaccines
Maglione MA et al.. Pediatrics 2014 · PMID 25086160 · DOI 10.1542/peds.2014-1079Systematic reviewindependent cross-checkabstract checkedSome vaccines have rare serious side effects (e.g. febrile seizures after MMR); these are very rare compared with the benefits.
Documents real but very rare serious vaccine harms.
Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Review vaccine side effects
- How was the study done?
Systematic review
- How many people, animals or samples were studied?
67 studies
- What was actually found?
Rare serious effects for some vaccines; no autism link
- How large was the observed effect?
Not pooled
- What do the results mean in everyday life?
Side effects exist but are rare
- What are the study's limitations?
No pooling
- What does it say about Elawady's specific claim?
Supports caution, not a ban
- Do the results apply to Germany and Europe?
High
- What can explicitly not be concluded from this study?
Exact absolute risks
No study in this group is marked as key.
Regional context
Germany / EU
Germany's Standing Committee on Vaccination (STIKO) publishes a standard vaccination calendar for infants, children, adolescents and adults (Impfkalender 2026, rki.de/impfkalender, fetched 2026-10-26).
Egypt
Egypt has compulsory childhood vaccinations. WHO regional data show 96-97% first-dose and 95-96% second-dose measles vaccine coverage in Egypt in 2023-2024, measles incidence falling from 2.2 per million to zero, and verified sustained measles and rubella elimination for 2024, while low-coverage countries in the region had large outbreaks, mostly among unvaccinated children (I-SRC-105).
What applies in my country?
General scientific assessment
False This claim is false: vaccines have rare, known side effects, but they prevent large numbers of illnesses and deaths; Egypt eliminated measles through high vaccination coverage.
This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.
References
- Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization.. Shattock AJ et al.. Lancet 2024 · PMID 38705159 · DOI 10.1016/S0140-6736(24)00850-X
- Vaccines for measles, mumps, rubella, and varicella in children.. Di Pietrantonj C et al.. Cochrane Database Syst Rev 2021 · PMID 34806766 · DOI 10.1002/14651858.CD004407.pub5
- Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies.. Taylor LE, Swerdfeger AL, Eslick GD. Vaccine 2014 · PMID 24814559 · DOI 10.1016/j.vaccine.2014.04.085
- Vaccines for preventing influenza in healthy adults.. Demicheli V et al.. Cochrane Database Syst Rev 2018 · PMID 29388196 · DOI 10.1002/14651858.CD001269.pub6
- Measles, Mumps, Rubella Vaccination and Autism: A Nationwide Cohort Study.. Hviid A et al.. Ann Intern Med 2019 · PMID 30831578 · DOI 10.7326/M18-2101
- Measles and Rubella Elimination Trends in the WHO Eastern Mediterranean Region, 2023-2024: Progress and Recent Epidemiological Shifts.. Farid M et al.. Vaccines (Basel) 2026 · PMID 42646678 · DOI 10.3390/vaccines14080659
- Safety of vaccines used for routine immunization of U.S. children: a systematic review.. Maglione MA et al.. Pediatrics 2014 · PMID 25086160 · DOI 10.1542/peds.2014-1079